Dr. Bairu is a physician, business executive, editor, author, and philanthropist. He has more than two decades of international experience in the biotechnology, pharmaceutical, global health and non-profit arenas. He is the founder and Chairman Emeritus of Serenus Biotherapeutics, Inc., a specialty biopharmaceutical company specialising in late-stage clinical development, in-licensing, and commercialising innovative therapies for the African market. Prior to that, Dr. Bairu concurrently served as Executive Vice President, Chief Medical Officer, and Head of Global Development for Elan and as President and CEO of Elan’s subsidiary, Speranza Therapeutics. He also served as Elan’s General Manager, was the head of Elan International, and has broad international experience in the United States, Europe, Latin America, South East Asia, the Middle East, and Africa. Prior to that, he worked for several leading biopharmaceutical companies, including Genentech and Johnson & Johnson, and served on the board of OneWorld Health, a not-for-profit pharmaceutical company funded by the Bill and Melinda Gates Foundation. Mr. Bairu is a graduate of the Technical and Commercial Institute VII, Milan, Italy (BBA) and of the University of Milan La Statale, Faculty of Medicine and Surgery, Milan, Italy (MD).